Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

CBS reports that roughly 170 workers were laid off from the FDA's Office of Inspections and Investigations. In related FDA news, the pharmaceutical industry is worried about the cuts; layoffs include ...

U.S. FDA Accepts New Drug Application Under Priority Review for sevabertinib (BAY 2927088) in HER2-Mutant Non-Small Cell Lung ...

Novel combination with efti has met the trial's primary endpoint of tumour hyalinization/fibrosis in the neoadjuvant setting for patients with resectable soft tissue sarcomaDetailed results are planne ...

The company’s application is pending before the FDA, which could potentially approve it by the end of the month, The Washington Post reported. The Washington Post: Billed As Nonaddictive, New Pain ...